Skip to content

Foresight Intracardiac Echocardiography System (ICE)

Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac Echocardiography (ICE) System

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03239444
Enrollment
13
Registered
2017-08-04
Start date
2017-04-24
Completion date
2018-12-24
Last updated
2019-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

ICE, Ablation, Trans-septal, Septum, Echocardiography

Brief summary

This study will evaluate the efficacy of the Foresight Intracardiac Echocardiography system ,with improved image quality, in guiding trans-septal punctures during atrial fibrillation ablation procedures.

Detailed description

The study will recruit 10 patients at a single center.

Interventions

DEVICEIntracardiac echocardiography imaging

Wide visualization of the the heart anatomy and additional devices used during atrial fibrillation ablation procedures.

Sponsors

Conavi
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient is at least 18 years old. * Patient is undergoing an atrial fibrillation ablation procedure. * Patient has a transesophageal echocardiogram (TEE) within the 48 hours prior to ablation procedure to rule out left atrial thrombus. * Patient provides informed, written consent for participation in the study.

Exclusion criteria

* Patients in whom placement of an ICE catheter in the right atrium for adequate atrial visualization is not technically feasible (as evaluated and determined by the physician/study investigator performing the procedure). * Patients in whom transseptal puncture is relatively contraindicated. * Patients in whom left atrial clot or dense spontaneous contrast is identified on TEE, which would increase thromboembolic risk. * Women of child bearing potential, in whom pregnancy cannot be excluded. * Patients unable to grant informed, written consent for participation in the study.

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the study device for guiding transseptal puncture in order to gain access to the left atrium of the heart during an ablation procedure in patients suffering with atrial fibrillation.For each patient, the individual physician satisfaction survey will be completed on the day of the procedure.The ability of the study device to identify the atrial septum during transseptal puncture will be evaluated by the physician on the day of the procedure and captured in the individual case report form. This will be based on the objective finding of whether the transseptal puncture was performed (Yes or No) under study device guidance. This information will be gathered for each patient in the individual case report form and presented qualitatively and as quantitative measures (percentage success).

Secondary

MeasureTime frameDescription
Collection of first human images with Conavi's Foresight System.An individual physician satisfaction survey will be completed for each case on the day of the procedure.The Conavi's Foresight System will be utilized to capture images of relevant human cardiac anatomical landmarks (e.g. crista terminalis, tricuspid valve, coronary sinus) while the catheter will be manipulated inside the heart during the procedure. The physician satisfaction survey will ask the physician to specifically tabulate structures that could be identified in a binary yes/no format. This kind of information will be gathered for each patient in the individual physician satisfaction surveys and presented qualitatively.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026